Analyzing the Role of Tofacitinib in Treatment of Alopecia Areata: A Retrospective Analysis from a Tertiary Care Center of North India

    January 2023 in “ National Journal of Physiology, Pharmacy and Pharmacology ”
    Shalabh Singla, Ranchit Narang, Vinay Shanker … Rajwinder Singh
    Studysummary In this study, tofacitinib treatment for six months significantly reduced hair loss severity in alopecia areata patients.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ejmanager.com →
    Discuss this study in the Community →

    Related research 6

    1. Case Report of Novel Combination of Anthralin and Calcipotriene Leading to Trichologic Response in Alopecia Areata JAAD case reports · 2019
    2. Alopecia Areata: A Multifactorial Autoimmune Condition Journal of autoimmunity · 2018
    3. Linear Alopecia Areata JAAD case reports · 2018
    4. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib PubMed · 2018
    5. Treating Resistant Cases of Alopecia Universalis Journal of cosmetology & trichology · 2018
    6. Overview of Alopecia Areata ˜The œjournal of investigative dermatology. Symposium proceedings/˜The œJournal of investigative dermatology symposium proceedings · 2013